Sexual Intercourse and Vaginal Absorption of Progesterone

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

February 5, 2024

Study Completion Date

February 29, 2024

Conditions
Infertility
Interventions
DRUG

Estradiol / Progesterone

Treatment with estradiol (Provames®, 3 mg morning and evening, or 6 mg per day) will start on the 1st or 2nd day of her period. This treatment is continued until the end of the study (discontinuation treatment after the blood test taken on Day 7). After ten days of minimum estradiol treatment (and up to 7 days later to be working days), vaginal progesterone treatment will start in the evening on Day 0 (400 mg, Progestan®, evening and morning, ie 800 mg per day).

BEHAVIORAL

Sexual event

A sexual intercourse (protected or not protected by condoms) will take place in a pre-defined order for each participant within one hour of the administration of the progesterone ovum on the evening of Day 2 and Day 6.

Trial Locations (1)

34295

CHU de Montpellier, Montpellier

All Listed Sponsors
collaborator

IBSA Institut Biochimique SA

INDUSTRY

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

University Hospital, Montpellier

OTHER